SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Biotechs >

Anavex Life Sciences Corp (AVXL)

Add AVXL Price Alert      Hide Sticky   Hide Intro
Moderator: blanka, TheHound, 123tom, kevindenver, TomP1, Rubyred77
Search This Board: 
Last Post: 5/23/2017 11:43:01 PM - Followers: 701 - Board type: Free - Posts Today: 0

Anavex Life Sciences Corp (AVXL)

Company website:
Company Address:
51 West 52nd Street, 7th floor
New York, NY
10019 USA

CIK:  0001314052
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s, CNS diseases and various types of cancer, which have significant unmet medical needs.
ANAVEX 2-73, the Company’s orally available drug candidate developed to treat Alzheimer’s through potential disease modification, has undergone an initial Phase 1 human clinical trial and was well tolerated in doses up to 55mg.  Results from pre-clinical studies indicate that ANAVEX 2-73 demonstrates anti-amnesic and neuroprotective properties.
A highly encouraging synergistic effect has also been observed between ANAVEX 2-73 and donepezil (Aricept®).  The combined therapeutics, referred to as “ANAVEX PLUS,” produced up to 80% greater reversal of memory loss in Alzheimer’s disease models versus when the drugs were used individually.
ANAVEX PLUS is believed to be a compelling commercial opportunity.  The clinical trial risk is lower because donepezil (Aricept®) is already on the market, with global sales of $4-billion annually.  Donepezil (Aricept®) is now generic and a patent application has been filed for ANAVEX PLUS which, if granted, would provide protection until 2033.

Patent Info:

Clinical Trials:
Recent News:
Company News Releases:
Share Structure:  See SEC filings
Investor Relations:

Marketing Details:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
AVXL News: Anavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Prese... 05/22/2017 07:00:00 AM
AVXL News: Statement of Changes in Beneficial Ownership (4) 05/15/2017 05:54:40 PM
AVXL News: Statement of Changes in Beneficial Ownership (4) 05/15/2017 05:54:40 PM
AVXL News: Quarterly Report (10-q) 05/10/2017 04:29:05 PM
AVXL News: Anavex Reports Fiscal Second Quarter 2017 Financial Results 05/10/2017 07:00:00 AM
#103034  Sticky Note To answer your good questions. falconer66a 04/26/17 10:18:09 AM
#101418  Sticky Note OK folks. While we realize that an occasional IH Admin [Edward] 04/18/17 06:45:04 AM
#99603  Sticky Note Basic biology concepts for Alzheimer’s disease (updated 4/1/2017) XenaLives 04/05/17 10:39:21 AM
#94047  Sticky Note Found a nice A-273 profile overview. Rubyred77 03/02/17 02:06:17 PM
#106038   Precision design is more important than popular approval...FDA XenaLives 05/23/17 11:43:01 PM
#106037   But the company would not have come across ExtremelyBullishZig 05/23/17 11:07:57 PM
#106036   Yes! Given my understanding of the science. basparks79 05/23/17 10:45:31 PM
#106035   bravo Zig. i don't get all the impatience mapman1010 05/23/17 10:44:52 PM
#106034   Would you have invested in a company whose ExtremelyBullishZig 05/23/17 10:40:08 PM
#106033   All of this frustrated-waiting comes as no surprise Aero-man 05/23/17 10:35:31 PM
#106032   Chris Cornell...ativan...need we say more? ExtremelyBullishZig 05/23/17 10:35:15 PM
#106031   Alzheimer's is a larger market and was the ExtremelyBullishZig 05/23/17 10:34:01 PM
#106030   And I'm having Pina Coladas on my yacht... basparks79 05/23/17 10:26:30 PM
#106029   You make a very good point... basparks79 05/23/17 10:22:59 PM
#106028   Is he a samson or a snape? Bearly Bullish 05/23/17 10:11:49 PM
#106027   Haven't some of us been wondering the same LakeshoreLeo1953 05/23/17 09:54:34 PM
#106026   Anxiety and depression are two huge markets. While nFUSZmywallet 05/23/17 09:53:02 PM
#106025   That makes me feel as though they are nFUSZmywallet 05/23/17 09:44:28 PM
#106024   If rare diseases are the fastest way to attilathehunt 05/23/17 09:39:18 PM
#106023   this is how impatient investors lose out......sorry to dadofmarcmax 05/23/17 09:36:33 PM
#106022   With all due respect, are you sure you dadofmarcmax 05/23/17 09:30:19 PM
#106021   This company is one big outsourced machine for mrplmer 05/23/17 09:29:37 PM
#106020   ...and "no significant change" to the chart... 123tom 05/23/17 09:29:19 PM
#106019   Because it is only profound in an unblinded ExtremelyBullishZig 05/23/17 09:24:00 PM
#106018   Epilepsy can be deadly. There is a known dadofmarcmax 05/23/17 09:19:44 PM
#106017   If the results are as profound as most attilathehunt 05/23/17 09:19:38 PM
#106016   So what are we going to hear first? basparks79 05/23/17 08:49:20 PM
#106015   Hi Plex Look. It's killing me too.. But only a McMagyar 05/23/17 08:33:10 PM
#106014   There has been no delays. Dr. Missling investor300 05/23/17 08:32:11 PM
#106013   What struck me is that A2-73 reduces insomnia. couldbebetter 05/23/17 08:07:44 PM
#106012   Rare diseases without treatments available can be approved ExtremelyBullishZig 05/23/17 08:03:39 PM
#106011   Mc--Anavex has been "bunting" for the last 2 plexrec 05/23/17 07:58:34 PM
#106010   Show me what Dr M has done such Amatuer17 05/23/17 07:01:12 PM
#106009   Right on.. And.. the good Dr is perhaps filing McMagyar 05/23/17 06:49:02 PM
#106008   Hey Xena, what do you know! We agree kld2 05/23/17 06:40:39 PM
#106007   And great for business development...adding value to the pipeline. ExtremelyBullishZig 05/23/17 06:23:02 PM
#106006   Well I think of the times I root McMagyar 05/23/17 06:17:42 PM
#106005   tick-tock tick-tock tick-tock and so plexrec 05/23/17 06:10:33 PM
#106004   I think part of the delay may be XenaLives 05/23/17 06:02:26 PM
#106003   Because this isn't a circus or a stock promo. XenaLives 05/23/17 06:01:02 PM
#106002   IR today said Anavex "has not announced participation kld2 05/23/17 05:51:42 PM
#106001   They can't start p3 without funding. Doc is riverterracekrew 05/23/17 05:50:24 PM
#106000   Once one approval is granted, won't the situation chrismiss_everyday 05/23/17 05:39:14 PM
#105999   Yeah sometimes that is how I feel. Vango54 05/23/17 05:37:21 PM
#105998   Trail ---- a beaten path through rough country Jimbo50 05/23/17 05:30:21 PM
#105997   I agree. Lets hope they figure out the Vango54 05/23/17 05:26:32 PM
#105996   I am more concerned about the quality of ExtremelyBullishZig 05/23/17 05:10:58 PM
#105995   Maybe I am mistaken but all of the Vango54 05/23/17 05:09:03 PM
#105994   Have to agree with six....been getting "promises" for plexrec 05/23/17 05:06:58 PM
#105993   If you had listened to any of Dr. ExtremelyBullishZig 05/23/17 05:00:51 PM
#105992   I hope I can explain myself,being that I sixpack 05/23/17 04:48:39 PM
#105991   I think what Sixpack was trying to convene Vango54 05/23/17 04:31:33 PM
#105990   Would you rather Anavex NOT get any grants? Djia 05/23/17 04:23:35 PM
#105988   SLB chart, updated EOD 23May2017, no significant change wildcard235 05/23/17 04:11:34 PM